Skip to main content
Erschienen in: Clinical Neuroradiology 2/2023

15.12.2022 | Review Article

Common Data Elements Analysis of Mechanical Thrombectomy Clinical Trials for Acute Ischemic Stroke with Large Core Infarct

verfasst von: Mohamed Sobhi Jabal, Mohamed K. Ibrahim, Jade Thurnham, Kevin M. Kallmes, Hassan Kobeissi, Sherief Ghozy, Nicole Hardy, Ranita Tarchand, Cem Bilgin, Jeremy J. Heit, Waleed Brinjikji, David F. Kallmes

Erschienen in: Clinical Neuroradiology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Clinical trials addressing large core acute ischemic stroke (AIS) are ongoing across multiple international groups. Future development of clinical guidelines depends on meta-analyses of these trials calling for a degree of homogeneity of elements across the studies. This common data element study aims to provide an overview of key features of pertinent large core infarct trials.

Methods

PubMed and ClinicalTrials.gov databases were screened for published and ongoing clinical trials assessing mechanical thrombectomy in patients with AIS with large core infarct. Nested Knowledge AutoLit living review platform was utilized to categorize primary and secondary outcomes as well as inclusion and exclusion criteria for patient selection in the trials.

Results

The most reported data element was ASPECTS score but with varied definitions of what constitutes large core. Non-utility-weighted modified Rankin score (mRS) was reported in 6/7 studies as the primary outcome, while the utility-weighted mRS was the outcome of interest in the TESLA trial, all of them at the 3 months mark, with only LASTE looking for mRS shift at the 6 months mark. Secondary outcomes had more variations. Mortality is reported separately only in 4/7 trials, all at the 3‑month mark. Additionally, the TENSION trial reported the frequency of serious adverse events, including mortality, at the 1‑week and 12-month mark.

Discussion

Overall, in large core trials there is a large degree of heterogeneity in the collected data elements. Differences in definition and timepoints render reaching a unified standard difficult, which hinders high quality meta-analyses and cohesive evidence-driven synthesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-22. Erratum in: Lancet. 2020;396:1562. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-22. Erratum in: Lancet. 2020;396:1562.
2.
Zurück zum Zitat Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344-418. Erratum in: Stroke. 2019;50:e440–1.CrossRefPubMed Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344-418. Erratum in: Stroke. 2019;50:e440–1.CrossRefPubMed
3.
Zurück zum Zitat Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk AM, von Kummer R, Gallofré M, Dávalos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.CrossRef Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk AM, von Kummer R, Gallofré M, Dávalos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.CrossRef
4.
Zurück zum Zitat Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378:11–21.CrossRef Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378:11–21.CrossRef
5.
Zurück zum Zitat Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–31.CrossRefPubMed Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–31.CrossRefPubMed
6.
Zurück zum Zitat Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708–18.CrossRef Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708–18.CrossRef
7.
Zurück zum Zitat Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, Johnston KC, Johnston SC, Khalessi AA, Kidwell CS, Meschia JF, Ovbiagele B, Yavagal DR; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–35.CrossRef Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, Johnston KC, Johnston SC, Khalessi AA, Kidwell CS, Meschia JF, Ovbiagele B, Yavagal DR; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–35.CrossRef
8.
Zurück zum Zitat Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guillemin F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Sourour NA, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol. 2018;17:895–904. Erratum in: Lancet Neurol. 2018;17:e2–3.CrossRefPubMed Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guillemin F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Sourour NA, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol. 2018;17:895–904. Erratum in: Lancet Neurol. 2018;17:e2–3.CrossRefPubMed
9.
Zurück zum Zitat Leslie-Mazwi TM, Altschul D, Simonsen CZ. Thrombectomy for Patients With Large Infarct Core in Practice: Where Should the Pendulum Swing? Stroke. 2021;52:3118–20.CrossRefPubMed Leslie-Mazwi TM, Altschul D, Simonsen CZ. Thrombectomy for Patients With Large Infarct Core in Practice: Where Should the Pendulum Swing? Stroke. 2021;52:3118–20.CrossRefPubMed
10.
Zurück zum Zitat Ren Z, Huo X, Ma G, Tong X, Kumar J, Pressman E, Chen W, Yuan G, Wang AY, Wei M, Zhang J, Nan G, Zhu Q, Liu Y, Zhang L, Song W, Zhou Z, Wang G, Li T, Luo J, Wang E, Ling W, Ju D, Song C, Liu SD, Gui L, Li T, Liu Y, Zhao J, Guo Z, Zheng H, Sun Y, Xu N, Wang YJ, Miao Z; ANGEL-ASPECT Investigators and ANGEL-ASPECT Steering Committee. Selection criteria for large core trials: rationale for the ANGEL-ASPECT study design. J Neurointerv Surg. 2022;14:107–10.CrossRefPubMed Ren Z, Huo X, Ma G, Tong X, Kumar J, Pressman E, Chen W, Yuan G, Wang AY, Wei M, Zhang J, Nan G, Zhu Q, Liu Y, Zhang L, Song W, Zhou Z, Wang G, Li T, Luo J, Wang E, Ling W, Ju D, Song C, Liu SD, Gui L, Li T, Liu Y, Zhao J, Guo Z, Zheng H, Sun Y, Xu N, Wang YJ, Miao Z; ANGEL-ASPECT Investigators and ANGEL-ASPECT Steering Committee. Selection criteria for large core trials: rationale for the ANGEL-ASPECT study design. J Neurointerv Surg. 2022;14:107–10.CrossRefPubMed
11.
Zurück zum Zitat Jadhav AP, Hacke W, Dippel DWJ, Simonsen CZ, Costalat V, Fiehler J, Thomalla G, Bendszus M, Andersson T, Mattle HP, Leslie-Mazwi TM, Mokin M, Yoo AJ, Zaidat OO, Sheth SA, Jovin TG, Liebeskind D. Select wisely: the ethical challenge of defining large core with perfusion in the early time window. J Neurointerv Surg. 2021;13:497–9.CrossRefPubMed Jadhav AP, Hacke W, Dippel DWJ, Simonsen CZ, Costalat V, Fiehler J, Thomalla G, Bendszus M, Andersson T, Mattle HP, Leslie-Mazwi TM, Mokin M, Yoo AJ, Zaidat OO, Sheth SA, Jovin TG, Liebeskind D. Select wisely: the ethical challenge of defining large core with perfusion in the early time window. J Neurointerv Surg. 2021;13:497–9.CrossRefPubMed
12.
Zurück zum Zitat Sarraj A, Campbell B, Ribo M, Hussain MS, Chen M, Abraham MG, Lansberg MG, Mendes Pereira V, Blackburn S, Sitton CW, Budzik RF, Pérez de la Ossa N, Arenillas JF, Wu T, Blasco J, Mullen M, Schaafsma J, Tsai JP, Sangha N, Kozak O, Gibson D, Warach S, Cordato D, Manning NW, Kleinig TJ, Olivot JM, Elijovich L, Tsivgoulis G, Alexandrov A, Jabbour P, Yan B, Kasner SE, Arthur AS, Parsons M, Grotta JC, Hassan AE, Albers GW; SELECT2 Investigators and SELECT2 Steering Committee. SELECTion criteria for large core trials: dogma or data? J Neurointerv Surg. 2021;13:500–4.CrossRefPubMed Sarraj A, Campbell B, Ribo M, Hussain MS, Chen M, Abraham MG, Lansberg MG, Mendes Pereira V, Blackburn S, Sitton CW, Budzik RF, Pérez de la Ossa N, Arenillas JF, Wu T, Blasco J, Mullen M, Schaafsma J, Tsai JP, Sangha N, Kozak O, Gibson D, Warach S, Cordato D, Manning NW, Kleinig TJ, Olivot JM, Elijovich L, Tsivgoulis G, Alexandrov A, Jabbour P, Yan B, Kasner SE, Arthur AS, Parsons M, Grotta JC, Hassan AE, Albers GW; SELECT2 Investigators and SELECT2 Steering Committee. SELECTion criteria for large core trials: dogma or data? J Neurointerv Surg. 2021;13:500–4.CrossRefPubMed
13.
Zurück zum Zitat Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007;8:38.CrossRefPubMedPubMedCentral Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007;8:38.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ioannidis JP, Horbar JD, Ovelman CM, Brosseau Y, Thorlund K, Buus-Frank ME, Mills EJ, Soll RF. Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants. BMJ. 2015;350:h72.CrossRefPubMed Ioannidis JP, Horbar JD, Ovelman CM, Brosseau Y, Thorlund K, Buus-Frank ME, Mills EJ, Soll RF. Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants. BMJ. 2015;350:h72.CrossRefPubMed
15.
Zurück zum Zitat Harburg L, McCormack E, Kenney K, Moore C, Yang K, Vos P, Jacobs B, Madden CJ, Diaz-Arrastia R, Bogoslovsky T. Reliability of the NINDS common data elements cranial tomography (CT) rating variables for traumatic brain injury (TBI). Brain Inj. 2017;31:174–84.CrossRefPubMed Harburg L, McCormack E, Kenney K, Moore C, Yang K, Vos P, Jacobs B, Madden CJ, Diaz-Arrastia R, Bogoslovsky T. Reliability of the NINDS common data elements cranial tomography (CT) rating variables for traumatic brain injury (TBI). Brain Inj. 2017;31:174–84.CrossRefPubMed
16.
Zurück zum Zitat Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.CrossRefPubMedPubMedCentral Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.CrossRefPubMedPubMedCentral
17.
20.
Zurück zum Zitat Yoshimura S, Uchida K, Sakai N, Yamagami H, Inoue M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Morimoto T. Randomized Clinical Trial of Endovascular Therapy for Acute Large Vessel Occlusion with Large Ischemic Core (RESCUE-Japan LIMIT): Rationale and Study Protocol. Neurol Med Chir (Tokyo). 2022;62:156–64.CrossRef Yoshimura S, Uchida K, Sakai N, Yamagami H, Inoue M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Morimoto T. Randomized Clinical Trial of Endovascular Therapy for Acute Large Vessel Occlusion with Large Ischemic Core (RESCUE-Japan LIMIT): Rationale and Study Protocol. Neurol Med Chir (Tokyo). 2022;62:156–64.CrossRef
26.
Zurück zum Zitat Kallmes DF, Rabinstein A, Brinjikji W. Letter by Kallmes et al Regarding Article, “Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0–5”. Stroke. 2019;50:e219.CrossRefPubMed Kallmes DF, Rabinstein A, Brinjikji W. Letter by Kallmes et al Regarding Article, “Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0–5”. Stroke. 2019;50:e219.CrossRefPubMed
27.
Zurück zum Zitat Dijkland SA, Voormolen DC, Venema E, Roozenbeek B, Polinder S, Haagsma JA, Nieboer D, Chalos V, Yoo AJ, Schreuders J, van der Lugt A, Majoie CBLM, Roos YBWEM, van Zwam WH, van Oostenbrugge RJ, Steyerberg EW, Dippel DWJ, Lingsma HF; MR CLEAN Investigators. Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study. Stroke. 2018;49:965–71.CrossRefPubMedPubMedCentral Dijkland SA, Voormolen DC, Venema E, Roozenbeek B, Polinder S, Haagsma JA, Nieboer D, Chalos V, Yoo AJ, Schreuders J, van der Lugt A, Majoie CBLM, Roos YBWEM, van Zwam WH, van Oostenbrugge RJ, Steyerberg EW, Dippel DWJ, Lingsma HF; MR CLEAN Investigators. Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study. Stroke. 2018;49:965–71.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Budhdeo S, Chari A, Harrison O, Blazeby J. Patient-centred healthcare outcome measures: towards a unified architecture. J R Soc Med. 2014;107:300–2.CrossRefPubMedPubMedCentral Budhdeo S, Chari A, Harrison O, Blazeby J. Patient-centred healthcare outcome measures: towards a unified architecture. J R Soc Med. 2014;107:300–2.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Grinnon ST, Miller K, Marler JR, Lu Y, Stout A, Odenkirchen J, Kunitz S. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods. Clin Trials. 2012;9:322–9.CrossRefPubMedPubMedCentral Grinnon ST, Miller K, Marler JR, Lu Y, Stout A, Odenkirchen J, Kunitz S. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods. Clin Trials. 2012;9:322–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Common Data Elements Analysis of Mechanical Thrombectomy Clinical Trials for Acute Ischemic Stroke with Large Core Infarct
verfasst von
Mohamed Sobhi Jabal
Mohamed K. Ibrahim
Jade Thurnham
Kevin M. Kallmes
Hassan Kobeissi
Sherief Ghozy
Nicole Hardy
Ranita Tarchand
Cem Bilgin
Jeremy J. Heit
Waleed Brinjikji
David F. Kallmes
Publikationsdatum
15.12.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 2/2023
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-022-01239-x

Weitere Artikel der Ausgabe 2/2023

Clinical Neuroradiology 2/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.